↓ Skip to main content

Antipsychotic medication versus placebo for people with both schizophrenia and learning disability

Overview of attention for article published in Cochrane database of systematic reviews, October 2004
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
Published in
Cochrane database of systematic reviews, October 2004
DOI 10.1002/14651858.cd000030.pub2
Pubmed ID
Authors

Lorna Duggan, Jane Brylewski

Abstract

Antipsychotic medication is the standard treatment for people with learning disability and schizophrenia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
Unknown 100 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 15%
Researcher 13 13%
Student > Ph. D. Student 9 9%
Other 8 8%
Student > Doctoral Student 8 8%
Other 25 25%
Unknown 23 23%
Readers by discipline Count As %
Medicine and Dentistry 28 28%
Psychology 17 17%
Nursing and Health Professions 10 10%
Social Sciences 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 9 9%
Unknown 28 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2016.
All research outputs
#8,465,483
of 25,466,764 outputs
Outputs from Cochrane database of systematic reviews
#9,672
of 13,111 outputs
Outputs of similar age
#24,626
of 75,740 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 46 outputs
Altmetric has tracked 25,466,764 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 13,111 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 75,740 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.